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Purpose: The aim of this study was to evaluate the appropriateness of using computed tomography
(CT) to cone-beam CT (CBCT) deformable image registration (DIR) for the application of calculating
the “dose of the day” received by a head and neck patient.
Methods: NiftyReg is an open-source registration package implemented in our institution. The affine
registration uses a Block Matching-based approach, while the deformable registration is a GPU im-
plementation of the popular B-spline Free Form Deformation algorithm. Two independent tests were
performed to assess the suitability of our registrations methodology for “dose of the day” calculations
in a deformed CT. A geometric evaluation was performed to assess the ability of the DIR method to
map identical structures between the CT and CBCT datasets. Features delineated in the planning CT
were warped and compared with features manually drawn on the CBCT. The authors computed the
dice similarity coefficient (DSC), distance transformation, and centre of mass distance between fea-
tures. A dosimetric evaluation was performed to evaluate the clinical significance of the registrations
errors in the application proposed and to identify the limitations of the approximations used. Dose
calculations for the same intensity-modulated radiation therapy plan on the deformed CT and replan
CT were compared. Dose distributions were compared in terms of dose differences (DD), gamma
analysis, target coverage, and dose volume histograms (DVHs). Doses calculated in a rigidly aligned
CT and directly in an extended CBCT were also evaluated.
Results: A mean value of 0.850 in DSC was achieved in overlap between manually delineated and
warped features, with the distance between surfaces being less than 2 mm on over 90% of the pixels.
Deformable registration was clearly superior to rigid registration in mapping identical structures be-
tween the two datasets. The dose recalculated in the deformed CT is a good match to the dose calcu-
lated on a replan CT. The DD is smaller than 2% of the prescribed dose on 90% of the body’s voxels
and it passes a 2% and 2 mm gamma-test on over 95% of the voxels. Target coverage similarity was as-
sessed in terms of the 95%-isodose volumes. A mean value of 0.962 was obtained for the DSC, while
the distance between surfaces is less than 2 mm in 95.4% of the pixels. The method proposed provided
adequate dose estimation, closer to the gold standard than the other two approaches. Differences in
DVH curves were mainly due to differences in the OARs definition (manual vs warped) and not due
to differences in dose estimation (dose calculated in replan CT vs dose calculated in deformed CT).
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Conclusions: Deforming a planning CT to match a daily CBCT provides the tools needed for the
calculation of the “dose of the day” without the need to acquire a new CT. The initial clinical ap-
plication of our method will be weekly offline calculations of the “dose of the day,” and use this
information to inform adaptive radiotherapy (ART). The work here presented is a first step into a
full implementation of a “dose-driven” online ART. © 2014 Author(s). All article content, except
where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.
[http://dx.doi.org/10.1118/1.4864240]
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1. INTRODUCTION
A radiotherapy treatment starts with the acquisition of a
computerized tomography (CT) scan, which is used to plan
an individualized treatment for the patient. The treatment is
then delivered over several weeks, based on the premise that
the anatomy is unchanged since the planning stage. Possi-
ble changes are considered by including treatment margins
when delineating volumes of interest. Patient positioning ver-
ification is performed using image-guidance. Cone-beam CT
(CBCT) is a popular imaging method that provides valuable
3D information of the patient in treatment position. However,
the imaging quality is inferior compared to CT,1 resulting in
incorrect Hounsfield units (HU) for dose calculations.2 It is
well known that patient’s anatomy can vary within a fraction,
with swallowing and respiratory motion,3 and from fraction
to fraction, with changes in bladder/bowel filling and tumor
shrinkage.4 The concept of adaptive radiotherapy (ART) sug-
gests a change of paradigm in radiotherapy:5 the stationary
anatomy is replaced by a variable anatomy, by utilizing daily
imaging in the radiotherapy process.6
ART is a very broad subject and full clinical implemen-
tation requires further developments in computational power,
image guidance, dose verification, and plan adaptation.6, 7 It
is widely accepted that deformable image registration (DIR)
algorithms will play a vital role in ART:8–10 the planning CT
(pCT) can be deformed to match the daily anatomy (CBCT)
for calculating the “dose of the day,” the deformation field can
be used for automatic recontouring and the daily dose distri-
butions can be warped back to the pCT for dose summation.11
This study is focused on head and neck (HN) patients. Sev-
eral studies show that HN patients’ anatomy changes during
the course of the treatment, and that this results in dosimet-
ric changes from the original plan.4, 12, 13 It is clear that some
patients require at least one replan,14 but it is not clear which
benefits the most from ART and when is the right time for in-
tervention. Currently, in University College London Hospital
(UCLH) the decision to replan is based on clinical experience
and offline review of CBCTs acquired. A more desirable ap-
proach would be to estimate the dose actually received by the
patient during treatment (“dose of the day”), and use this dosi-
metric information to feed the decision-making process.
To calculate the “dose of the day” and assess if the cur-
rent plan is still acceptable, an image of the patient in treat-
ment position with structures of interest delineated is neces-
sary, and DIR can provide a solution to answer both those
needs. We optimized a DIR algorithm implemented at our
institution for CT-to-CBCT registrations in HN patients, and
investigated its suitability to correctly estimate the “dose of
the day” for an intensity modulated radiation therapy (IMRT)
treatment. Two other common approaches suggested in the lit-
erature to calculate the “dose of the day” are based on image
guidance with CT imaging,15 and direct dose calculations on
the CBCT, using pixel correction techniques16, 17 or relative
electron density calibration.18, 19 The first increases the dose
given to the patient in the image guidance protocols and re-
quires an in-room CT scanner, which is not available in our
practice. The second is more limited by the inherent proper-
ties of CBCT imaging, such as proneness to motion artifacts,
increased noise, reduced contrast, and limited field-of-view
(FoV). It also requires delineation of structures of interest,
which can be challenging in a CBCT scan.
DIR validation is challenging due to the lack of gold stan-
dards in clinical and nonclinical settings.20 While there is a
wide variety of studies assessing the quality of CT-CT de-
formable registration with patient data,8, 21 for CT-CBCT the
studies are scarcer and usually focused on the deformation
properties rather than dosimetry.22–25 In this work we use im-
age inspection, feature-based evaluation, and comparison of
dose distributions to assess the suitability of our DIR algo-
rithm implementation for the clinical application of dose cal-
culations in HN patients.
2. METHODS AND MATERIALS
2.A. Patient data acquisition
Retrospective data from five head and neck patients treated
in our clinic and referred for possible replan was used in this
study (Table I). All patients underwent IMRT with a planned
dose of 65 Gy delivered in 30 daily fractions. Patient position-
ing was assured by appropriate head-rest and a personalized
HN and shoulder mask.
The imaging protocol consisted of a planning CT (GE
Widebore 16 slice system) with contrast injection, and weekly
CBCTs (On-board imaging v1.4, Varian Medical Systems,
Palo Alto, CA) acquired in treatment position. The CBCTs
were acquired in half-fan mode, full rotation, 110 kVp,
20 mA, 20 ms, with a maximum FoV of 45 cm in diameter,
and 16 cm in length. Imaging resolution was 0.977 × 0.977
× 2.5 mm and 0.879 × 0.879 × 2 mm for the CT and CBCT
scans, respectively.
The treatment isocenter is usually set to bony anatomy
on the identifiable vertebrae and does not represent any
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TABLE I. Patient characteristics.
Pt. no. Age (y) Gender Tumor site TNM classification Replan (Y/N) Wa (%) Vextb (%) LPTVc (mm) VPTVd (%)
1 64 F Oropharynx T3N1M0 N N/A − 8.5 +15 6.5
2 61 M Larynx T3N1M0 Y +0.4 − 3.5 +8 0.5
3 73 F Base of the tongue T4N2cM0 Y − 1.7 − 4.7 0 0.0
4 60 M Larynx T3N0M0 Y − 4.4 − 12.4 +14 3.0
5 64 M Pharyngeal wall T4N2cM0 Y − 11.7 − 8.6 −26 9.4
aW = relative weight variation at plan evaluation.
bVext = relative external volume variation at plan evaluation, in the region imaged by the CBCT.
cLPTV = length of the target volume outside the CBCT in the superior/inferior direction, at replan referral.
dVPTV = target volume fraction not imaged by the CBCT, at replan referral.
normalization point or high dose region. The CBCT is aligned
to the pCT following a standardized online image guidance
protocol for isocenter alignment based on manual rigid regis-
tration to the cervical spinal vertebrae.
Replanning referral occurred when the CBCT offline re-
view study found the spinal canal or brainstem outside their
respective planning organ at risk volume, the external con-
tour decreased more than 5 mm and/or if the immobilization
mask was no longer effective. By rigidly aligning the pCT
with the CBCT and defining the new body external contour
on the pCT based on the CBCT external, target coverage and
possible overdosage to organs-at-risk (OARs) were verified,
and the decision to replan taken. Four of these patients were
replanned midway. A replan CT (rCT) was acquired in the
same scanner as the pCT (with contrast) and a new plan built
from scratch—a new immobilization mask was necessary but
the previous positioning was reproduced as close as possi-
ble. Typically the last two weeks of treatment were completed
with the new plan.
2.B. NiftyReg
NiftyReg is an open-source registration package imple-
mented by our institution’s Centre of Medical Image Com-
puting (http://cmic.cs.ucl.ac.uk/home/software/). While the
affine registration implemented in NiftyReg uses a Block
Matching-based approach,26 the deformable registration is a
GPU implementation of the popular B-spline Free Form De-
formation algorithm using Normalized Mutual Information
(NMI) as similarity measure.27, 28
The registrations were defined by a set of parameters pre-
viously optimized to suit the datasets being registered.29, 30
NiftyReg implements a multiresolution approach, and our
registrations were carried out using three resolution levels.
The B-spline control point grid is placed on the CBCT by
aligning the second control point with the centre of the first
voxel, as shown in Fig. 1(a). The control point spacing equals
five voxels.
Two regularization terms were used: bending energy,
which encourages a smoothly varying deformation field,27
and logarithm of the determinant of the jacobian, which pe-
nalizes large volume changes.31 A folding correction scheme
is applied every iteration and to the final deformation field.
When folding occurs the correction scheme updates the con-
trol point coefficients in the vicinity of folded voxels to try
and produce a folding-free transformation.32 The folding cor-
rection scheme ensures the invertibility of the deformation
field.
NMI metric with 32 bins was preferred as similarity
measure over other popular measures, such as the sum
of squared differences (SSD) and global cross-correlation
(CC), since it handles not only the nonlinear relation-
ship between CT and CBCT intensities but also the lo-
cal variations of intensity characteristic of CBCT imaging.
The registrations were optimized using a conjugate gradient
optimization.
FIG. 1. Standard B-spline control point grid covering: (a) the CBCT vol-
ume only and (b) the CBCT volume extended to cover the CT field of view.
The second control point position matches the centre of the first voxel of the
image.
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In our pipeline, the patient images and structures were ex-
ported from the treatment planning system (TPS) in DICOM
format to a standalone registration workstation. Our registra-
tion workstation had an Intel Xeon CPU E25606 (2.13GHz,
12GB RAM) with a NVIDIA Tesla C2070 GPU card (14 mul-
tiprocessors, 6 GB dedicated memory). A rigid registration
was first applied in order to estimate the global alignment be-
tween the pCT and the CBCT. The obtained transformation
was then used to initialize the deformable registration. The
deformable registrations using images at full resolution ran in
approximately 1 min. The output deformation field was used
to propagate the contours from the planning CT to the de-
formed CT, and the results saved in DICOM format. Both the
deformed CT and warped structures were then imported back
in the TPS for dose calculations.
A well-known issue with CBCT imaging is that the limited
FoV often makes the images unusable for treatment planning
due to missing patient information.19 Methods proposed to
handle this issue include acquiring two consecutive CBCTs,33
or directly using pCT slices to extend the CBCT.11 We esti-
mated the deformation outside the CBCT FoV by continuity,
using the initial rigid alignment and the regularization of the
deformable registration. The CBCT volume was extended in
the superior/inferior direction, to cover the whole CT FoV.
Figure 1(b) shows the effect this has on the B-spline control
point placement. The deformation outside the FoV was ini-
tialized using the rigid alignment. During the registration the
transformation is optimized over the whole of the extended
volume—as there is no image data to drive the registration
outside the field it is purely driven by the constraint terms in
these regions. This has the effect of causing a smooth transi-
tion between the image driven deformation inside the field of
view and the rigid alignment outside the FoV. A good rigid
alignment between the pCT and CBCT is then required, and
it provides a good approximation mostly in the superior re-
gion, as the patient’s head moves in a rigid fashion. The su-
perior region is usually the most important due to presence
of OARs such as brainstem and parotids. The brainstem only
moves rigidly, but the parotids can shrink and migrate,12 and
if not imaged the registration will likely represent the wrong
deformation.
2.C. Evaluation of the DIR suitability for “dose of the
day” calculations
Two independent tests were performed to assess the ap-
propriateness of our registrations methodology for “dose of
the day” calculations in a deformed CT. A geometric evalua-
tion was performed to assess the ability of our DIR method to
map identical structures between the CT and CBCT datasets.
Features delineated in the pCT were deformed using the out-
put deformation field and compared with the same features
manually drawn on the CBCT. We compared the results ob-
tained with those of using a rigid-only registration of the ver-
tebrae. A dosimetric evaluation was performed to evaluate the
impact of the registrations errors in the application proposed,
to identify the limitations of our out-of-field approximation
and assess how our method compares with other approaches.
FIG. 2. Features identified on the CT and CBCT images for the geomet-
ric evaluation: bony anatomy (vertebrae C1, C4, and C7) and left and right
sternocleidomastoid muscles (LSCM and RSCM).
Dose distributions for the same IMRT plan were calculated
on the deformed pCT and rCT, and compared. In this second
test our method results were compared not only with those
from a rigid-only registration of the vertebrae, which approx-
imates our institution’s current alignment protocol, but also
with dose calculations directly on an calibrated and extended
CBCT.16, 17
2.C.1. Geometric evaluation
The purpose of this test was to assess the DIR ability to
align the same anatomical features in CT and CBCT images.
For each patient a set of easily identifiable features was drawn
by the same clinical expert on both the pCT and the CBCT
(Fig. 2). The CBCT used for each patient was the last acquired
before replan referral. Due to the noise and low contrast in-
herent to CBCT imaging, it is difficult to delineate points or
delineate structures with confidence and consistency. The fea-
tures were chosen to be structures that could be unequivo-
cally identified in both scans and that gave an indication of
how well the registration accounts for patient positioning er-
rors and weight loss. Vertebrae C1, C4, and C7 were used
because they are only subject to rigid motion and cover the
length of the cervical spinal canal. External body contour and
right and left sternocleidomastoid muscles were used as soft
tissue structures. The two muscles are adjacent to the region
that contains the neck lymph nodes. Deformation between
scans may affect their shape and position, and therefore nodal
dose.34 Typical HN OARs, such as parotids and brainstem,
were not considered in this evaluation because they cannot be
unequivocally seen in a CBCT scan.
Considering that A and B are the set of voxels that define
the volumes of the manual and deformed features while ˜A and
˜B define the corresponding surfaces, three metrics were used
to describe the similarity between the features:
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 Dice similarity coefficient (DSC)
DSC = 2 |A ∩ B||A| + |B| .
 Distribution of Euclidean distances between surfaces’
points, also known as the distance transform (DT).21
DT (a) = min (‖a − b‖) , a ∈ ˜A, ∀b ∈ ˜B.
DT was computed bi-directionally and properties of the
distribution, such as mean value, were calculated.
 Centroid position error (CoM)
CoM = ‖aCoM − bCoM‖.
The metrics presented provide complementary informa-
tion about the overlap between volumes (DSC), closeness be-
tween the surfaces (DT), and spatial positioning of the fea-
tures (CoM).
2.C.2. Dose comparison
In this second test our aim was to show that we can deform
the pCT into an image which is functionally equivalent to a
rCT as far as dose calculation is concerned. To test this hy-
pothesis, four different dose distributions were computed for
each patient:
(i) recalculated dose in the rCT (DrCT), considered as
gold-standard;
(ii) recalculated dose in the deformed pCT, (DDIR), the
method we propose;
(iii) recalculated dose in a rigidly aligned pCT (DRIG), our
current clinical approach;
(iv) recalculated dose in a calibrated CBCT with supe-
rior/inferior extension (DCBCT).
In an ideal situation the rCT and CBCT would have been
acquired at the same time, or at least in the same day, so that
the two modalities contained the same (or comparable) ge-
ometric information. However, using retrospective data such
effort is not possible since there is no clinical reason to ac-
quire a CT and a CBCT on the same day. The CBCT used for
each patient was the one acquired on the first fraction of the
second plan. Since the rCT and following CBCT are not ac-
quired simultaneously, but 5–7 days apart, noticeable changes
to the patients’ positioning and anatomy can occur between
the scans. To minimize the errors in dose estimation due to
discrepancies between the rCT and the CBCT, we actually
registered the pCT to a simulated CBCT, obtained by deform-
ing the real CBCT to match the rCT. This simulated CBCT
is closer to the ideal dataset discussed above. We could have
deformed the rCT to match the CBCT instead but we opted
against it for three reasons: (i) since we are trying to repro-
duce the dose calculated on a rCT we did not want to modify
the rCT in any way, (ii) the plan isocenter is intrinsically de-
fined in the rCT (further explanation on this point below), and
(iii) since CBCT inherently has lower imaging quality possi-
ble errors in the deformed CBCT will be less noticeable than
FIG. 3. Diagram of the data and registrations used in the dosimetric evalu-
ation. The structures included in this study were the brainstem, spinal canal,
and parotid glands.
similar errors in deforming the rCT. To calculate DCBCT the
simulated CBCT values were replaced, pixel by pixel, with
CT values and the image was extended in the superior and in-
ferior direction using the corresponding rigidly aligned pCT
slices. The relationship between CT and CBCT values was
obtained using the Catphan-504 (Phantom Laboratory, NY)
calibration phantom. Images of the phantom were acquired
and the average HU for each of its constituting materials was
calculated for each of the imaging modalities. The conversion
curve between CT and CBCT numbers was approximated by
a quadratic polynomial. Figure 3 shows the data used and reg-
istrations performed for each patient.
Doses were calculated for an IMRT plan using Varian
Eclipse External Beam Planning System analytical
anisotropic algorithm with the highest available resolu-
tion (1 mm). For each patient the same IMRT plan, including
beam arrangement, monitor units and fluence maps, were
employed. The choice of IMRT plan should be clinically
relevant, so a dose distribution the patient was treated with
was chosen. The plan chosen to perform the dose calculations
was the replan, which was built and optimized in the rCT.
This minimizes the issues with the isocenter definition both
in the gold-standard, our method and extended CBCT. The
uncertainties with isocenter positioning are only an issue
when calculating DRIG. The isocenter uncertainty positioning
in this case was dealt with by using our clinical protocol for
isocenter alignment (described in Sec. 2.A).
The dose distributions were compared considering dose-
differences (DD), gamma analysis, and similarity of the 95%
isodose region (representing target coverage).
The gamma analysis method compares a reference (Dref)
and calculated (Dcal) dose distributions using acceptance
criteria.35 It combines two important dose comparison crite-
ria: distance to agreement (dM) and dose-difference (DM).
The gamma quality index (γ ) at each point of the calculated
dose distribution is given by
γ (rcal) = min{(rcal, rref}∀{rref},
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FIG. 4. Geometric matching of manual and warped features overlaid on the
CBCT image. Blue corresponds to manual-only, red to warped-only voxels,
and green to the region of agreement. The features shown are (from left to
right): (a) left sternocleidomastoid muscle (LSCM), C4, and right sternoclei-
domastoid muscle (RSCM), (b) vertebrae C1, C4, and C7; and (c) LSCM,
C1, and RSCM.
where








r (rcal, rref) = |rref − rcal|
and
δ (rcal, rref) = Dref (rref) − Dcal(rcal).
The pass-fail criteria are: γ (rcal) ≤ 1 the calculation passes,
γ (rcal) > 1 the calculation fails. The criterion used was dM
= 2 mm and DM = 2%.
2.C.3. Propagation of structures and
“dose of the day”
The dose analysis was extended to examine the impact
within different OARs. In clinical settings, dose volume
histograms (DVHs) are routinely used to assess if the plan
is appropriate for the patient, by displaying in a concise and
comprehensive way the information of dose delivered both
to targets and OARs. DVHs were computed using both man-
ually drawn and warped structures of interested. The struc-
tures were delineated by the radiographers as part of clinical
practice. Complementary to DVH analysis, overlap between




Figure 4 shows a representative example of the matching of
manual and warped features. The visual matching of the fea-
tures is satisfactorily after registration, particularly for com-
plexly shaped features such as the vertebrae.
In Table II we present the mean DSC, DT, and CoM ob-
tained for different types of features. Figure 5 shows the com-
plete information of the distribution of DT values, for dif-
ferent feature and registration types. DIR aligns the features
well and considerably better than rigid registration, and the
results obtained are more consistent between different struc-
tures types. The results obtained are also poorer in soft tissue
region than in bone anatomy. Inherent lower soft tissue con-
trast in the CBCT degrades both the registration accuracy and
the quality of manual segmentations. The tail of the DT dis-
tribution, and consequently maximum DT values, are thought
to be more related with local poor manual segmentation than
to registration errors.
3.B. Dose comparison
Overall DDIR matches DrCT well (Fig. 6). The dose simi-
larity results were analyzed based on different regions of the
TABLE II. Mean values (± standard deviation) of dice similarity coefficient (DSC), distance transform (DT), and centroid position error (CoM) obtained
using deformable (DIR) and rigid-only (RIG) registrations. The results are grouped by different structure type: external contours, soft tissues (left and right
sternocleidomastoid muscles), and bony anatomy (vertebrae C1, C4, and C7).
External counters Bony anatomy Soft tissues Overall
Measure RIG DIR RIG DIR RIG DIR RIG DIR
DSC 0.945 ± 0.017 0.986 ± 0.001 0.722 ± 0.122 0.846 ± 0.027 0.643 ± 0.143 0.790 ± 0.056 0.733 ± 0.157 0.850 ± 0.076
DT2mma (%) 31.4 ± 8.5 3.6 ± 1.5 20.4 ± 17.7 5.3 ± 3.5 29.2 ± 21.6 8.7 ± 4.9 25.2 ± 18.6 6.2 ± 4.3
DTmeanb (mm) 1.9 ± 0.8 0.4 ± 0.1 1.4 ± 0.6 0.8 ± 0.1 1.9 ± 1.0 1.0 ± 0.2 1.6 ± 0.8 0.8 ± 0.3
DTstdc (mm) 2.8 ± 1.1 1.3 ± 0.4 1.2 ± 0.4 0.9 ± 0.2 1.6 ± 0.6 1.1 ± 0.4 1.6 ± 0.8 1.0 ± 0.4
DT95%d (mm) 7.8 ± 3.2 2.1 ± 0.3 3.5 ± 1.4 2.4 ± 0.6 4.9 ± 2.3 2.9 ± 1.1 4.7 ± 2.6 2.5 ± 0.9
DTmaxe (mm) 22.0 ± 9.2 18.5 ± 8.2 6.7 ± 2.2 5.5 ± 1.6 10.3 ± 4.1 8.5 ± 4.0 10.4 ± 7.2 8.6 ± 6.2
CoM(mm) 4.4 ± 1.4 0.8 ± 0.3 2.5 ± 1.6 0.8 ± 0.4 3.6 ± 2.8 2.1 ± 0.6 3.2 ± 2.2 1.2 ± 0.8
aDT2mm = fraction of the distance transform distribution larger than 2 mm.
bDTmean = mean value of the distance transform distribution.
cDTstd = standard deviation of the distance transform distribution.
dDT95% = 95% percentile of the distance transform distribution.
eDTmax = maximum value of the distance transform distribution.
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FIG. 5. Distribution of distance transform (DT) values for deformable (DIR,
in grey) and rigid only (RIG, in black) registrations. The results are grouped
by different structure type: external contours, soft tissues (left and right ster-
nocleidomastoid muscles), and bony anatomy (vertebrae C1, C4, and C7).
patient (Table III), providing evidence of the dose behavior
outside the CBCT FoV. DDIR results were better than the DRIG
and DCBCT results in all regions, although the major bene-
fits of using DDIR were in the region imaged in the CBCT
where most anatomical changes occur and higher dose is
delivered.
Target coverage similarity was assessed in terms of the
95%-isodose volumes obtained for DDIR, DRIG, and DCBCT in
comparison with DrCT. Our method resulted in a mean value
of 0.962 ± 0.015 (range: 0.937–0.978) for the DSC, while the
distance between surfaces is less than 2 mm in 95.4% ± 5.8%
(range: 85.6%–99.8%) of the pixels. For DRIG and DCBCT
the values obtained were, respectively, 0.929 ± 0.016 (range:
0.908–0.950), and 0.957 ± 0.011 (range: 0.940–0.971) for
DSC, and 79.8 ± 5.3 (range: 73.2%–87.9%) and 93.1 ± 2.7
(range: 88.9%–96.1%) for DT2mm.
For a particular patient the 95%-isodose curve similarity
was considerably poorer when compared with the results ob-
tained for the remaining patients. We observed that the CBCT
was acquired more superiorly than usual, and so the inferior
volume of the high dose region was not fully imaged. As a re-
sult, for this particular patient our estimation outside the FoV
was not adequate in the inferior direction (where the transfor-
mations are not majorly rigid).
FIG. 6. Rigid (left), extended CBCT (middle), and deformable registrations (right): (a) intensity difference image with the replan CT, (b) dose difference with
DrCT as percentage of the prescribed dose (%pD), and (c) gamma analysis. Between 60% and 90% of the treatment field-of-view was imaged in the CBCT in
the available datasets. Treatment (black line) and CBCT (purple line) fields-of-view are indicated in (a). Deformable results are clearly better than rigid and
extended CBCT. Most striking registration errors, and therefore dose estimation errors, occurred in the skin and airways. The inconsistency in HU is visible for
the CBCT results, particularly in the shoulder region. This degrades the accuracy of the dose estimation in a part of the high dose region and spinal canal.
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TABLE III. Similarity between dose distributions [deformable (DDIR), rigid-only (DRIG), and extended CBCT
(DCBCT)] and gold-standard (replan CT) within different regions of interest: mean values (and standard deviation)
for DD (2% pass-percentage and mean absolute value) and gamma tests.
Dose difference (DD) test
Pass- Mean test Gamma test (2%/2mm criterion)
Region of interest Method percentage (%) value (%pD) Pass-percentage (%)
Treatment FoV DDIR 87.0 (±6.4) 1.6 (±1.0) 94.3 (±5.4)
DRIG 75.6 (±4.2) 3.9 (±0.8) 84.7 (±3.3)
DCBCT 78.5 (±1.0) 2.0 (±0.5) 90.5 (±2.5)
CBCT FoV DDIR 90.0 (±0.9) 1.2 (±0.2) 97.1 (±1.1)
DRIG 74.2 (±3.0) 4.4 (±0.8) 83.9 (±2.2)
DCBCT 79.6 (±8.0) 1.6 (±0.5) 92.6 (± 4.0)
Nonimaged treatment FoV DDIR 86.0 (±10.5) 1.7 (±1.7) 92.1 (±8.2)
DRIG 84.1 (±8.7) 2.1 (±1.3) 90.4 (±6.7)
DCBCT 84.1 (±8.5) 2.0 (±1.3) 90.5 (±6.6)
95% isodose volume DDIR 93.4 (±8.1) 0.7 (±0.2) 97.1 (±4.3)
DRIG 67.8 (±6.8) 2.1 (±0.6) 80.0 (±6.2)
DCBCT 83.7 (±4.5) 1.2 (±0.2) 90.3 (±4.1)
The DD inside the OARs are most relevant clinically
(Fig. 7). DDIR dose-differences are clinically insignificant
inside OARs, and the results found are superior to those from
other dose estimation approaches. The poor image quality of
the CBCT in the inferior direction (i.e., neck and shoulders)
is responsible for the inferiority of DCBCT in comparison with
DDIR. This affects both the dose estimation in the high dose
region (Table III and Fig. 6) and in the spinal canal (Fig. 7).
The inconsistency in HU is less problematic in the remaining
OARs.
3.C. Propagation of structures and “dose of the day”
Figure 8 contains DVHs calculated using (i) DrCT and man-
ually drawn structures on the rCT, (ii) DDIR and the same man-
ual structures, and (iii) DDIR and structures warped from the
pCT. Measures of overlap obtained for OARs show that al-
though the volumes are similar the differences can be non-
negligible in the DVHs. The mean DSC obtained was 0.810
± 0.044, 0.822 ± 0.062, 0.760 ± 0.048, and 0.770 ± 0.010,
for the brainstem, spinal canal, left parotid, and right parotid,
FIG. 7. Dose difference: distribution of values (as percentage of the prescribed dose,%pD), for different OARs and dose calculations.
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FIG. 8. DVH for different OARs using DrCT and manually drawn structure
(rCT), DDIR and structures warped from the pCT (DIR), and DDIR and man-
ually drawn structures [DIR(rCT)].
respectively. From Fig. 8 it can be seen that differences in
DVHs were mainly due to differences in the OARs def-
inition (manual vs warped) and not due to differences in
dose estimation (DrCT vs DDIR). The same trend was found
for the errors in estimating the maximum and mean doses
to an OAR (Dmax and Dmean). Using DDIR combined
with manually drawn structures on the rCT the mean value
obtained for Dmean was 0.1% ± 0.1% of the prescribed
dose (pD) (range: 0.0%–0.3%pD), while for Dmax was
0.3% ± 0.2%pD (range: 0.0%–0.6%pD). However, using the
warped structures these errors increased to 2.4% ± 2.1%pD
(range: 0.3%–7.8%pD) and 1.5% ± 1.6%pD (range: 0.1%–
6.2%pD), respectively.
4. DISCUSSION
Regarding the geometric evaluation, all metrics showed an
improvement when comparing deformable to rigid registra-
tion, up to a relative improvement of 80%. The values found
for DSC are comparable to the ones obtained by Castadot
et al. using CT-CT DIR.36 DT metrics and CoM values were
comparable to image resolution. Combining the DSC, DT,
and CoM we can evaluate the ability of the DIR method to
map identical structures between the CT and CBCT datasets.
However, each of these quantities can be misleading on its
own. For example, DSC is inherently bigger for larger struc-
tures, such as the external contours, and in this case DT is a
better measure of similarity between features.
One of the main limitations of our geometric evaluation is
not including localization of anatomical landmarks. Anatom-
ical landmarks were not used in this study due to the diffi-
culty detected by our clinical expert in consistently identify-
ing points in a CBCT image. The uncertainty in landmark
locations could produce misleading accuracy results, so we
opted to only use structures in the geometric evaluation. Fur-
thermore, we consider that for our current goal of calculating
the “dose of the day” accurate point-to-point mapping is not
required.
The method presented allows for accurate dose calcula-
tions, comparable to doses recalculated on a replan CT and
superior to both our current clinical approach and dose cal-
culations on the CBCT (with extended FoV). CBCT images
include larger amounts of scattering than CT, resulting in
larger variation in HU values that limit the HU calibration
and reliability.1 The CBCT calibrations are done using a small
phantom which provides consistent results in such a small
FoV. However, for larger volumes the calibration is no longer
consistent which has a considerable impact in dose calcula-
tions. Figure 6 shows the effect in dose estimation of such in-
consistency in HU in the neck and shoulders region. Imaging
larger volumes result in increased scatter and reduced trans-
mission. The increase in scatter introduces nonuniformities
and additional quantum noise to the reconstructed image.37
This indicates the need for more specific and appropriate cal-
ibration phantoms for CBCT, which should cover the size of
the treatment region. The choice of phantom is crucial as oth-
ers showed different phantoms result in very different rela-
tive electron density calibration curves, and particularly the
Catphan may not be the most appropriate due to issues with
its bone-equivalent material.18 While we think our results are
indicative of how reliable CBCT currently is for direct dose
calculations, it was not in the scope of this paper to optimize
treatment planning on CBCT images. Our imaging protocol
was not optimized for that purpose, and so the calculations
were clearly suboptimal. In our opinion calculating dose dis-
tributions directly on CBCT images is still an active area of re-
search and the fact that specialized calibrations and optimiza-
tions are required is a current disadvantage of such methods.
The deteriorated image quality of CBCT leads to serious con-
cerns about its reliability for direct dose calculations. CT is
still far superior to CBCT for treatment planning, and DIR is
a good interim solution for ART until CBCT data are directly
usable.
Our results show promise to obtain dosimetric information
even outside the CBCT FoV. The interpolation of the infor-
mation outside the FoV allows performing dose calculations
even when the CBCT FoV is smaller than the treatment FoV.
Although we do propose a method for estimating the transfor-
mation, and hence the anatomy, outside of the CBCT FoV, we
do not claim this will always give trustworthy results. If there
is significant deformation outside the FoV then our method
will not be able to recover this. Such deformations occurred
for one of the patients included in our study where the CBCT
field of view did not extend far enough in the inferior direc-
tion. Further research will be required to study the validity
of our approximation outside the on-board imaging. For fu-
ture clinical applications, the imaged region must be selected
properly to minimize possible out of field errors on critical
regions of the individual patient. For example, if the major
concern is the dose given, to the brainstem, then the brain-
stem should be imaged. If target coverage is more important,
the high dose region should be properly captured. Informing
the imaging procedures will be even more important for big-
ger patients and/or tumors.
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Figure 8 shows how structure delineation has an important
impact in plan evaluation. Structure contours deviations ex-
plain the differences in DVHs and mean/maximum doses to
OARs. The overlap found between OARs is similar to values
reported by Tsuji et al. for CT-CT DIR.8 Visually we find that
most discrepancies in spinal canal and brainstem are actually
due to differences in defining the extent of these organs in
the superior direction in the different scans. Generating ap-
propriate structure delineations for ART is an important and
on-going area of research,8, 21, 24 which is beyond the scope
of this paper. In future applications of the tool presented and
validated here, deformed structures will be used as a start-
ing point to speed up the evaluation process, but will likely
require manual verification and editing to be used clinically.
Extra care must be taken if modifying targets during ART.
Even though authors suggest the use of DIR to monitor tumor
shrinkage,38 in our case warping target volumes may not be
appropriate as they are usually not visible in CBCT imaging.
Also, even if the gross tumor volume (GTV) shrinkage is vis-
ible, there is no evidence that microscopic proliferation has
shrunk in the same proportion. Guidelines for target propaga-
tion are still being developed by our group and others. Includ-
ing routine functional imaging, such as magnetic resonance
imaging (MRI), in the ART workflow may provide not only a
solution for target propagation but also early evidence of the
patient response to the treatment.39, 40
We have validated the use of DIR for calculating the “dose
of the day,” but this does not necessarily guarantee correct
point-to-point matching. Point-to-point matching is impor-
tant when handling dose remapping and summation, but is
very difficult to validate because the true correspondence is
unknown.21 Dose remapping and summation is very sensitive
to the actual displacement map since small errors in defor-
mation can result in significant changes in dose at points in
high dose gradient regions.41 Additionally, warping the “dose
of the day” back to the original pCT for summation requires
the inverse of the pCT-CBCT transformation. Therefore, sym-
metric and diffeomorphic registrations are desired to ensure
invertibility and remove bias from the direction of the reg-
istration. Such approaches are currently being investigated,31
and preliminary results indicate that our DIR framework can
be successfully used for dose summation.
Further work will also focus on measuring the accuracy of
the deformation maps and further improvements of the regis-
trations. One of the sources of errors in DIR is the inherent de-
formation of bony elements, which physically can only move
rigidly. Rigidity penalty terms, that constrain the registration
to be rigid in regions of interest, are desired in a realistic de-
formable registration algorithm to increase the accuracy of the
tissue mapping.42 Other similarity measures can also be inves-
tigated to improve the robustness of the registrations.43, 44
The patients included in this study had considerable
anatomical changes during the course of their treatment. We
consider the tests applied to our registration quite severe as
those patients were selected from the group of identified sen-
sitive cases treated in our practice. The registrations were par-
ticularly challenging for the dose comparisons since not only
anatomical changes but also different positioning systems had
to be reproduced. For this reason we expect our routine clini-
cal cases to be less demanding.
The initial clinical application of our method will be
weekly offline calculations of the “dose of the day” to help
inform the decision of whether the current plan is still accept-
able. At this point if a plan is found to be unacceptable our
current replan pathway will be followed. Replanned patients
will be used on further validation to support the effectiveness
and efficiency of the proposed method. With more patients it
may be possible to understand the relationship between DIR
and dose errors, which could be used to establish quick and
easy methods for detecting regions where DIR errors are sig-
nificant from a dose calculation point of view. On a longer
term the aim is for our tool to be employed for the replan
procedure itself and remove the need for acquiring a new CT
when a new immobilization is not necessary. The final aim
is to enable the implementation of a controlled “dose-driven”
ART approach that can be built into the patient pathway: to
perform routine online modifications to the treatment plan
based on the dose that has already been delivered.
5. CONCLUSIONS
This work presents a proof-of-principle of the application
of an in-house developed deformable registration for ART
purposes. We have developed, optimized, and evaluated a CT-
to-CBCT DIR and our experiments have demonstrated that
using a pCT scan deformed to match a CBCT scan results
in similar dose calculations to those performed on a new CT
scan. The dose differences were clinically acceptable, and
our method provided dose estimation closer to the gold stan-
dard than calculations in a rigidly aligned pCT and extended
CBCT. The results obtained support the use of nonrigid regis-
tration and provide further evidence in the challenging objec-
tive of validating deformable registration for routine clinical
use. The work here presented is a first step into a full imple-
mentation of a “dose-driven” online ART.
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